Mainz, Germany

Maxime Paven

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Covestro Deutschland Ag. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maxime Paven. Retrieved from https://idiyas.com/inventor/maxime-paven-76mtdh0v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maxime Paven - Innovator in Polyphosphazene Technology

Introduction

Maxime Paven is an inventor based in Mainz, Germany. He is currently employed at Covestro Deutschland AG. Although he has not yet been granted any patents, he is actively involved in innovative research and development.

Latest Patent Applications

Maxime Paven's notable patent application is titled "Polyphosphazene and Molding Compound Containing the Polyphosphazene." This invention relates to a polyphosphazene produced through a method that includes converting a cyclical phosphazene using phenol in the presence of a base, followed by further conversion using a special aromatic diphenol. The molar ratio of phenol to cyclical phosphazene used in this process ranges from 3.5:1 to 1:1. The invention also encompasses a method for producing the polyphosphazene and a molding compound that includes the polyphosphazene and a thermoplastic polymer.

Conclusion

Maxime Paven is a promising inventor in the field of polyphosphazene technology, contributing to advancements through his innovative patent applications. His work at Covestro Deutschland AG highlights his commitment to research and development in this specialized area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…